Post-Marketing surveillance for the safety of GARDASIL® and GARDASIL®9 in a cohort of Chinese women

10/07/2020
02/07/2024
EU PAS number:
EUPAS36132
Study
Finalised
Documents
Study protocol
Initial protocol
English (9.48 MB - PDF) View document
Study results
Study results
English (1.09 MB - PDF) View document
English (789.7 KB - PDF) View document
Study report
Other information